IBDEI0F6 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7298,2)
 ;;=CSME in DM Type I^267840^362.83
 ;;^UTILITY(U,$J,358.3,7299,0)
 ;;=362.01^^49^556^32
 ;;^UTILITY(U,$J,358.3,7299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7299,1,3,0)
 ;;=3^Diabetic Retinopathy Nos
 ;;^UTILITY(U,$J,358.3,7299,1,4,0)
 ;;=4^362.01
 ;;^UTILITY(U,$J,358.3,7299,2)
 ;;=^12257
 ;;^UTILITY(U,$J,358.3,7300,0)
 ;;=362.02^^49^556^72
 ;;^UTILITY(U,$J,358.3,7300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7300,1,3,0)
 ;;=3^Prolif Diab Retinopathy
 ;;^UTILITY(U,$J,358.3,7300,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,7300,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,7301,0)
 ;;=362.03^^49^556^64
 ;;^UTILITY(U,$J,358.3,7301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7301,1,3,0)
 ;;=3^Nonprolf Db Retnoph Nos
 ;;^UTILITY(U,$J,358.3,7301,1,4,0)
 ;;=4^362.03
 ;;^UTILITY(U,$J,358.3,7301,2)
 ;;=^332786
 ;;^UTILITY(U,$J,358.3,7302,0)
 ;;=362.04^^49^556^61
 ;;^UTILITY(U,$J,358.3,7302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7302,1,3,0)
 ;;=3^Mild Nonprolf Db Retnoph
 ;;^UTILITY(U,$J,358.3,7302,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,7302,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,7303,0)
 ;;=362.05^^49^556^62
 ;;^UTILITY(U,$J,358.3,7303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7303,1,3,0)
 ;;=3^Mod Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,7303,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,7303,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,7304,0)
 ;;=362.06^^49^556^98
 ;;^UTILITY(U,$J,358.3,7304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7304,1,3,0)
 ;;=3^Sev Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,7304,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,7304,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,7305,0)
 ;;=379.27^^49^556^103
 ;;^UTILITY(U,$J,358.3,7305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7305,1,3,0)
 ;;=3^Vitreomacular Adhesion
 ;;^UTILITY(U,$J,358.3,7305,1,4,0)
 ;;=4^379.27
 ;;^UTILITY(U,$J,358.3,7305,2)
 ;;=^340517
 ;;^UTILITY(U,$J,358.3,7306,0)
 ;;=115.02^^49^556^44
 ;;^UTILITY(U,$J,358.3,7306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7306,1,3,0)
 ;;=3^Histoplasma Capsulatum Retinitis
 ;;^UTILITY(U,$J,358.3,7306,1,4,0)
 ;;=4^115.02
 ;;^UTILITY(U,$J,358.3,7306,2)
 ;;=^266890
 ;;^UTILITY(U,$J,358.3,7307,0)
 ;;=190.5^^49^556^58
 ;;^UTILITY(U,$J,358.3,7307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7307,1,3,0)
 ;;=3^Malig Retina
 ;;^UTILITY(U,$J,358.3,7307,1,4,0)
 ;;=4^190.5
 ;;^UTILITY(U,$J,358.3,7307,2)
 ;;=^73530
 ;;^UTILITY(U,$J,358.3,7308,0)
 ;;=198.4^^49^556^59
 ;;^UTILITY(U,$J,358.3,7308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7308,1,3,0)
 ;;=3^Malig Secondary Choroid
 ;;^UTILITY(U,$J,358.3,7308,1,4,0)
 ;;=4^198.4
 ;;^UTILITY(U,$J,358.3,7308,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,7309,0)
 ;;=200.00^^49^556^81
 ;;^UTILITY(U,$J,358.3,7309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7309,1,3,0)
 ;;=3^Reticulosarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,7309,1,4,0)
 ;;=4^200.00
 ;;^UTILITY(U,$J,358.3,7309,2)
 ;;=^72635
 ;;^UTILITY(U,$J,358.3,7310,0)
 ;;=228.03^^49^556^38
 ;;^UTILITY(U,$J,358.3,7310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7310,1,3,0)
 ;;=3^Hemangioma Retina
 ;;^UTILITY(U,$J,358.3,7310,1,4,0)
 ;;=4^228.03
 ;;^UTILITY(U,$J,358.3,7310,2)
 ;;=^267700
 ;;^UTILITY(U,$J,358.3,7311,0)
 ;;=228.09^^49^556^39
 ;;^UTILITY(U,$J,358.3,7311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7311,1,3,0)
 ;;=3^Hemangioma,Oth Sites
 ;;^UTILITY(U,$J,358.3,7311,1,4,0)
 ;;=4^228.09
 ;;^UTILITY(U,$J,358.3,7311,2)
 ;;=^55270
 ;;^UTILITY(U,$J,358.3,7312,0)
 ;;=360.00^^49^556^73
 ;;^UTILITY(U,$J,358.3,7312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7312,1,3,0)
 ;;=3^Purulent Endophthalmitis,Unspec
